Longevity Vision

longevity.vision

VCMatch tracks Longevity Vision as an investor focused on Biotech, Medtech, and Digital Health companies. Upload your deck to compare your startup against the full private matching profile.

Check Size

Not specified

Stages

Not specified

Focus Areas

Biotech, Medtech, Digital Health

Geography

Not specified

Investment Thesis

The firm invests in platform-driven companies and technologies that enable ‘longevity breakthroughs’ by targeting the biological pathways of aging and building a diversified ecosystem of developers and platforms. They favor founder-led, platform companies spanning gene therapy, AI-driven drug discovery, diagnostics, regenerative technologies, wearables and healthcare delivery — aiming to assemble a portfolio that covers ‘every major area of aging research’ and accelerate translation through integrated, technology-first approaches.

Is Longevity Vision right for your startup?

Upload your pitch deck to compare your startup against VCMatch's private investor profile, including fit, timing, and next-step signals.

See If You're a Match View Sample Match

Investment Focus

Who should take a closer look

Longevity Vision is most relevant for founders raising venture-backed rounds in Biotech, Medtech, Digital Health, and AI/ML.

Focus statement

They focus on longevity and age-related disease innovation — investing in platform technologies (e.g., gene therapy, gene writing, AI-based drug discovery, RNA platforms, diagnostics, organ regeneration, biosensors and integrated healthcare) and building an ecosystem of drug developers and holdings that target the pathways of aging.

Value Add

Platform-first portfolio spanning multiple enabling technologies (examples listed: 'Gene therapy platform', 'Gene writing platform', 'Endless RNA platform', 'AI-based drug discovery platform', 'Aging clocks platform', 'Organ regeneration technology').
Ecosystem/holding approach: explicitly building an 'Ecosystem of drug developers' and a 'Longevity biotech holding' to cover broad areas of aging research.
Founder-focused and venture-creation ties: many portfolio entries call out founders and Flagship Pioneering relationships (e.g., multiple 'Founders:' lines and 'Flagship Pioneering' credited across companies).
Integrated, technology-driven drug development: emphasis on 'an AI-based drug discovery and development engine' and fully integrated healthcare platforms.
Broad scope including therapeutics, diagnostics, devices, delivery, and service models (e.g., 'digital stethoscope', 'handheld ultrasound', 'health and wellness centers', 'clean meat platform').